| Chetan E Chitnis, David Schellenberg, Johan Vekemans, Edwin J Asturias, Philip Bejon, Katharine A Collins, Brendan S Crabb, Socrates Herrera, Miriam Laufer, N Regina Rabinovich, Meta Roestenberg, Adelaide Shearley, Halidou Tinto, Marian Wentworth, Kate O’Brien, Pedro Alonso Building momentum for malaria vaccine research and development: key considerations (Journal Article) In: Malar. J., vol. 19, no. 1, pp. 421, 2020, ISSN: 1475-2875, (PMID: 33228666
PMCID: PMC7682132). @article{Chitnis2020-cj,
title = {Building momentum for malaria vaccine research and development: key considerations},
author = {Chetan E Chitnis and David Schellenberg and Johan Vekemans and Edwin J Asturias and Philip Bejon and Katharine A Collins and Brendan S Crabb and Socrates Herrera and Miriam Laufer and N Regina Rabinovich and Meta Roestenberg and Adelaide Shearley and Halidou Tinto and Marian Wentworth and Kate O'Brien and Pedro Alonso},
doi = {10.1186/s12936-020-03491-3},
issn = {1475-2875},
year = {2020},
date = {2020-11-23},
urldate = {2020-11-01},
journal = {Malar. J.},
volume = {19},
number = {1},
pages = {421},
publisher = {Springer Science and Business Media LLC},
abstract = {To maintain momentum towards improved malaria control and
elimination, a vaccine would be a key addition to the
intervention toolkit. Two approaches are recommended: (1)
promote the development and short to medium term deployment of
first generation vaccine candidates and (2) support innovation
and discovery to identify and develop highly effective,
long-lasting and affordable next generation malaria vaccines.},
note = {PMID: 33228666
PMCID: PMC7682132},
keywords = {Control; Elimination; Malaria; Research and development; Vaccine},
pubstate = {published},
tppubtype = {article}
}
To maintain momentum towards improved malaria control and
elimination, a vaccine would be a key addition to the
intervention toolkit. Two approaches are recommended: (1)
promote the development and short to medium term deployment of
first generation vaccine candidates and (2) support innovation
and discovery to identify and develop highly effective,
long-lasting and affordable next generation malaria vaccines. |